Related Experiment Video
Updated: Jun 12, 2026

Application of Laser Microdissection to Uncover Regional Transcriptomics in Human Kidney Tissue
Published on: June 9, 2020
Identification of alternatively spliced GRIM-19 mRNA in kidney cancer tissues
1Signal Transduction Laboratory, Institute of Molecular and Cell Biology, Agency for Science, Technology and Research, Singapore.
Abstract:
Gene associated with Retinoid-Interferon-induced Mortality (GRIM)-19 was originally identified as a regulatory gene necessary for interferon-beta and retinoic acid-induced cell death. Further studies revealed that GRIM-19 is a subunit of mitochondrial respiratory chain complex I. Previous studies show that the expression of GRIM-19 is lost or severely depressed in a number of primary renal cell carcinomas (RCCs) and in some urinogenital tumors. Four point mutations were found in the GRIM-19 gene in mitochondria-rich (Hürthle) tumors and one point mutation was reported in RCC. In this study, we report an alternatively splicing form of GRIM-19 mRNA with intron 3 by reverse transcriptase PCR. This splicing variant is found in kidney tumor tissues but not in matched normal tissues. Furthermore, we found that in addition to GRIM-19, the protein level of NDUFS3, which is another mitochondrial complex I subunit, was also diminished in kidney tumor tissues when compared with paired normal tissues. Our finding suggested that the alternative splicing form of GRIM-19 is tumor tissue specific.
Insights
A novel alternative splicing form of the Gene associated with Retinoid-Interferon-induced Mortality (GRIM)-19 mRNA was discovered in kidney tumor tissues. This finding suggests GRIM-19 alternative splicing is specific to tumors, potentially impacting renal cell carcinoma development.
Area of Science:
- Molecular Biology
- Oncology
- Mitochondrial Biology
Background:
- Gene associated with Retinoid-Interferon-induced Mortality (GRIM)-19 is a mitochondrial complex I subunit.
- GRIM-19 expression is often reduced in renal cell carcinomas (RCCs) and other genitourinary tumors.
- Mutations in GRIM-19 have been previously identified in certain tumors.
Purpose of the Study:
- To investigate alternative splicing of GRIM-19 mRNA in kidney tumors.
- To determine if GRIM-19 alternative splicing is tumor-specific.
- To assess the protein levels of other mitochondrial complex I subunits in kidney tumors.
Main Methods:
- Reverse transcriptase PCR (RT-PCR) was used to detect GRIM-19 mRNA splicing variants.
- Kidney tumor tissues and matched normal tissues were analyzed.
- Protein levels of GRIM-19 and NDUFS3 were assessed.
Main Results:
- An alternatively spliced form of GRIM-19 mRNA, including intron 3, was identified.
- This splicing variant was present in kidney tumor tissues but absent in matched normal tissues.
- Protein levels of GRIM-19 and NDUFS3 were diminished in kidney tumor tissues compared to normal tissues.
Conclusions:
- The alternative splicing of GRIM-19 mRNA is specific to kidney tumor tissues.
- This aberrant splicing may contribute to the altered function of mitochondrial complex I in RCC.
- Further research is warranted to understand the functional implications of GRIM-19 alternative splicing in tumorigenesis.
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Non-LTR Retrotransposons

